1
ethyl H-phosphonate), −4.7 ppm (s, 1.01P, DPCP), −11.6 ppm
(s, 0.97P, DPP), −17.1 ppm (s, 1.0P, triphenylphosphate),
−25.0 ppm (s, 0.38P, TPPP). 31P coupled NMR: δ (CDCl3 +
tetrahydrofurfuryl alcohol) 11.3 and 6.9 ppm (dq, P–H coupling
706.6 Hz, J3 = 9.36 Hz, tetrahydrofurfuryl ethyl H-phosphonate
diester), 10.8 and 6.5 ppm (dq, P–H coupling 704.3 Hz, J3 =
9.14 Hz, tetrahydrofurfuryl ethyl H-phosphonate diester), 9.1
and 5.0 ppm (dt, P–H coupling 686.5 Hz, ethyl H-phosphonate).
1H NMR: δ (CDCl3 + tetrahydrofurfuryl alcohol) 7.73 and
5.95 ppm (d, P–H coupling 706.61 Hz, tetrahydrofurfuryl ethyl
H-phosphonate diester), 7.69 and 5.93 ppm (d, P–H coupling
704.3 Hz, tetrahydrofurfuryl ethyl H-phosphonate diester), 7.60
and 5.89 ppm (d, P–H coupling 686.8 Hz, ethyl H-phosphonate).
1H decoupled 31P NMR: δ (CDCl3 + tetrahydrofurfuryl alcohol
+ pyridine) 9.2 ppm (s, 0.53P, tetrahydrofurfuryl ethyl H-phos-
phonate diester), 8.6 ppm (s, 0.67P, tetrahydrofurfuryl ethyl
H-phosphonate diester), 7.0 ppm (s, 1.0P, ethyl H-phosphonate),
−4.7 ppm (s, 0.81P, DPCP), −11.6 ppm (s, 1.18P, DPP),
−17.1 ppm (s, 1.0P, triphenylphosphate), −25.0 ppm (s, 0.35P,
TPPP). MS (+ve, acetonitrile): (M + 1, 195, tetrahydrofurfuryl
ethyl H-phosphonate diester).
6.89 ppm (m), 3.09 ppm (s, 6H, N+(CH3)2 DMAP-DPCP); H
decoupled 31P NMR: δ (DPCP and DMAP in CDCl3) −5.0 ppm
(s, 3.09, DPCP), −13.1 ppm (s, 11.53, DMAP-DPCP),
−25.1 ppm (s, 1.0, TPPP). H NMR: δ (DMAP-HCl in CDCl3)
14.63 ppm (broad s, 1H, DMAP-HCCl), 8.15 ppm (s, 2H, HA
DMAP-HCl), 6.91 ppm (s, 2H, HB DMAP-HCl), 3.31 ppm
(s, 6H, N+(CH3)2 DMAP-HCl).
1
Abbreviations
DPCP diphenylchlorophosphate
DPP
diphenylphosphate
TPPP tetraphenylpyrophosphate
Acknowledgements
We are grateful to Avecia Biotechnology for support.
References
1 The Vitravene Study Group, Am. J. Opthalmol., 2002, 133, 467.
2 S. L. Beaucage, Curr. Opin. Drug Discovery Dev., 2008, 11, 203.
3 J. Tian, K. Ma and I. Saaem, Mol. BioSyst., 2009, 5, 714.
4 M. H. Caruthers, Science, 1985, 230, 281.
1H decoupled 31P NMR timescan kinetics
DPCP (51.6 mg, 0.19 mmol, 0.25 M) was added to a solution of
triethylammonium ethyl H-phosphonate (38.0 mg, 0.18 mmol,
0.24 M) and triphenylphosphate (31.3 mg, 0.1 mmol, 0.13 M)
in CDCl3 or d3-acetonitrile (0.75 ml). The sample was then ana-
5 G. Zon, New J. Chem., 2010, 34, 795.
6 R. B. Merrifield, Angew. Chem., Int. Ed. Engl., 1985, 24, 799.
7 R. H. Hall, A. Todd and R. F. Webb, J. Chem. Soc., 1957, 3291.
8 B. C. Froehler and M. D. Matteucci, Tetrahedron Lett., 1986, 27, 469.
9 B. C. Froehler, P. G. Ng and M. D. Matteucci, Nucleic Acids Res., 1986,
14, 5399.
1
lysed continuously by H decoupled 31P NMR. All individual
10 E. de Vroom, C. E. Dreef, H. van den Elst, G. A. van der Marel and
J. H. van Boom, Recl. Trav. Chim. Pays-Bas, 1988, 107, 592.
11 H. G. Khorana, Science, 1979, 203, 614.
NMR spectra were 16 scans per spectra.
12 P.J. Garegg, T. Regberg, J. Stawinski and R. Stromberg, Nucleosides,
Nucleotides Nucleic Acids, 1987, 6, 655.
Equilibrium studies
13 P. J. Guthrie, Can. J. Chem., 1979, 57, 236.
DPP (156.7 mg, 0.62 mmol) was dissolved in the chosen solvent
(0.4 ml) and aliquots (50 μl) were added to a solution of bis
diethyl pyro-di-H-phosphonate containing triphenylphosphate
(17.6 mg, 0.05 mmol) in the same solvent (0.6 ml) under a nitro-
gen atmosphere. The sample was then analysed by 1H decoupled
31P NMR and 31P coupled–31P coupled NMR COSY. The
position of DMAP–DPCP adduct formation was determined
from DPCP (78.0 mg, 0.29 mmol) in CDCl3 (0.75 ml) analysed
by both 1H and 1H decoupled 31P NMR. DMAP (55.mg,
14 Z. Luz and B. Silver, J. Am. Chem. Soc., 1961, 83, 4518.
15 J. Stawinski and A. Kraszewski, Acc. Chem. Res., 2002, 35, 952.
16 R. Stromberg, Nucleosides, Nucleotides Nucleic Acids, 2003, 22, 1.
17 Y. V. Dankov, N. V. Batchikova, N. V. Scaptsova, E. S. Besidsky and
A. V. Azhayev, Bioorg. Khim., 1988, 14, 615.
18 P. J. Garegg, T. Regberg, J. Stawinski and R. Stromberg, Nucleosides,
Nucleotides Nucleic Acids, 1987, 6, 283.
19 P. J. Garegg, I. Lindh, T. Regberg, J. Stawinski, R. Stromberg and
C. Henrichson, Tetrahedron Lett., 1986, 27, 4051.
20 B. C. Froehler and M. D. Mattuecci, Nucleosides Nucleotides, 1987, 6,
287.
21 P. J. Garegg, T. Regberg, J. Stawinski and R. Stromberg, Chemica
Scripta, 1986, 26, 59.
22 A. Zwierzak and A. Koziara, Tetrahedron, 1967, 23, 2243.
23 M. Breant and G. Demanga-Guerin, Bull. Soc. Chim. Fr., 1969, 2935.
24 R. L. Beniot and C. Buisson, Electrochim. Acta, 1973, 18, 105.
25 P. J. Garegg, J. Stawinski and R. Stromberg, J. Org. Chem., 1987, 52,
284.
26 J. H. Atherton, Avecia Biotechnology, personal communication.
27 I. Y. Dubey, V. A. Efimov, T. V. Lyapina and D. M. Fedoryak, Bioorg.
Khim., 1992, 18, 911; S. Sigurdsson and R. Stromberg, J. Chem. Soc.,
Perkin Trans. 2, 2002, 1682.
1
0.45 mmol) in CDCl3 (0.75 ml) analysed by H NMR. DPCP
(0.16 g, 0.57 mmol) was added to a solution of DMAP
(62.5 mg, 0.51 mmol) in CDCl3 (0.75 ml) and analysed by both
1H and 1H decoupled 31P NMR. DMAP hydrochloride
(80.9 mg, 0.51 mmol) in CDCl3 (0.75 ml) analysed by 1H
NMR: δ (DPCP in CDCl3) 7.32 ppm (m, phenyl protons DPCP)
1H decoupled 31P NMR: δ (DPCP in CDCl3) −4.6 ppm (s, 1P,
1
DPCP), −24.9 ppm (s, 0.02P, TPPP); H NMR: δ (DMAP in
CDCl3) 8.22 ppm (d, 2H, HA DMAP), 6.47 ppm (d, 2H, HB
DMAP), 2.97 ppm (s, 6H, N(CH3)2 DMAP). 1H NMR: δ
(DPCP and DMAP in CDCl3) 8.23 ppm (broad s, 2H, HA
DMAP-DPCP), 7.36 ppm (broad s, 2H, HB DMAP-DPCP),
28 V. F. Zarytova, E. M. Ivanova, D. G. Knorre, A. V. Lebedev,
A. I. Rezvukhin and E. V. Yarmolinskaya, Dokl. Akad. Nauk. SSSR.,
1979, 248, 1124.
29 A. Zwierzak and A. Koziara, Tetrahedron, 1967, 23, 2243.
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2012